This report contains market size and forecasts of Herpes Zoste Drug in global, including the following market information:
Global Herpes Zoste Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Herpes Zoste Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Herpes Zoste Drug companies in 2020 (%)
The global Herpes Zoste Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Zoste Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herpes Zoste Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Herpes Zoste Drug Market Segment Percentages, By Type, 2020 (%)
Acyclovir
Amenamevir
FV-100
GLS-5100
GSK-1437173A
NAL-3221
Others
Global Herpes Zoste Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Herpes Zoste Drug Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others
Global Herpes Zoste Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Herpes Zoste Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herpes Zoste Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Herpes Zoste Drug revenues share in global market, 2020 (%)
Key companies Herpes Zoste Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Herpes Zoste Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma Inc.
Beijing Minhai Biotechnology Co., Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences, Inc.
Foamix Pharmaceuticals Ltd.
GeneOne Life Science, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL, Inc.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Herpes Zoste Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Herpes Zoste Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Herpes Zoste Drug Overall Market Size
2.1 Global Herpes Zoste Drug Market Size: 2021 VS 2027
2.2 Global Herpes Zoste Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Herpes Zoste Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Herpes Zoste Drug Players in Global Market
3.2 Top Global Herpes Zoste Drug Companies Ranked by Revenue
3.3 Global Herpes Zoste Drug Revenue by Companies
3.4 Global Herpes Zoste Drug Sales by Companies
3.5 Global Herpes Zoste Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Herpes Zoste Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Herpes Zoste Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Herpes Zoste Drug Players in Global Market
3.8.1 List of Global Tier 1 Herpes Zoste Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Herpes Zoste Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Herpes Zoste Drug Market Size Markets, 2021 & 2027
4.1.2 Acyclovir
4.1.3 Amenamevir
4.1.4 FV-100
4.1.5 GLS-5100
4.1.6 GSK-1437173A
4.1.7 NAL-3221
4.1.8 Others
4.2 By Type - Global Herpes Zoste Drug Revenue & Forecasts
4.2.1 By Type - Global Herpes Zoste Drug Revenue, 2016-2021
4.2.2 By Type - Global Herpes Zoste Drug Revenue, 2022-2027
4.2.3 By Type - Global Herpes Zoste Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Herpes Zoste Drug Sales & Forecasts
4.3.1 By Type - Global Herpes Zoste Drug Sales, 2016-2021
4.3.2 By Type - Global Herpes Zoste Drug Sales, 2022-2027
4.3.3 By Type - Global Herpes Zoste Drug Sales Market Share, 2016-2027
4.4 By Type - Global Herpes Zoste Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Herpes Zoste Drug Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Herpes Zoste Drug Revenue & Forecasts
5.2.1 By Application - Global Herpes Zoste Drug Revenue, 2016-2021
5.2.2 By Application - Global Herpes Zoste Drug Revenue, 2022-2027
5.2.3 By Application - Global Herpes Zoste Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Herpes Zoste Drug Sales & Forecasts
5.3.1 By Application - Global Herpes Zoste Drug Sales, 2016-2021
5.3.2 By Application - Global Herpes Zoste Drug Sales, 2022-2027
5.3.3 By Application - Global Herpes Zoste Drug Sales Market Share, 2016-2027
5.4 By Application - Global Herpes Zoste Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Herpes Zoste Drug Market Size, 2021 & 2027
6.2 By Region - Global Herpes Zoste Drug Revenue & Forecasts
6.2.1 By Region - Global Herpes Zoste Drug Revenue, 2016-2021
6.2.2 By Region - Global Herpes Zoste Drug Revenue, 2022-2027
6.2.3 By Region - Global Herpes Zoste Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Herpes Zoste Drug Sales & Forecasts
6.3.1 By Region - Global Herpes Zoste Drug Sales, 2016-2021
6.3.2 By Region - Global Herpes Zoste Drug Sales, 2022-2027
6.3.3 By Region - Global Herpes Zoste Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Herpes Zoste Drug Revenue, 2016-2027
6.4.2 By Country - North America Herpes Zoste Drug Sales, 2016-2027
6.4.3 US Herpes Zoste Drug Market Size, 2016-2027
6.4.4 Canada Herpes Zoste Drug Market Size, 2016-2027
6.4.5 Mexico Herpes Zoste Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Herpes Zoste Drug Revenue, 2016-2027
6.5.2 By Country - Europe Herpes Zoste Drug Sales, 2016-2027
6.5.3 Germany Herpes Zoste Drug Market Size, 2016-2027
6.5.4 France Herpes Zoste Drug Market Size, 2016-2027
6.5.5 U.K. Herpes Zoste Drug Market Size, 2016-2027
6.5.6 Italy Herpes Zoste Drug Market Size, 2016-2027
6.5.7 Russia Herpes Zoste Drug Market Size, 2016-2027
6.5.8 Nordic Countries Herpes Zoste Drug Market Size, 2016-2027
6.5.9 Benelux Herpes Zoste Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Herpes Zoste Drug Revenue, 2016-2027
6.6.2 By Region - Asia Herpes Zoste Drug Sales, 2016-2027
6.6.3 China Herpes Zoste Drug Market Size, 2016-2027
6.6.4 Japan Herpes Zoste Drug Market Size, 2016-2027
6.6.5 South Korea Herpes Zoste Drug Market Size, 2016-2027
6.6.6 Southeast Asia Herpes Zoste Drug Market Size, 2016-2027
6.6.7 India Herpes Zoste Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Herpes Zoste Drug Revenue, 2016-2027
6.7.2 By Country - South America Herpes Zoste Drug Sales, 2016-2027
6.7.3 Brazil Herpes Zoste Drug Market Size, 2016-2027
6.7.4 Argentina Herpes Zoste Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Herpes Zoste Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Herpes Zoste Drug Sales, 2016-2027
6.8.3 Turkey Herpes Zoste Drug Market Size, 2016-2027
6.8.4 Israel Herpes Zoste Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Herpes Zoste Drug Market Size, 2016-2027
6.8.6 UAE Herpes Zoste Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Corporate Summary
7.1.2 Astellas Pharma Inc. Business Overview
7.1.3 Astellas Pharma Inc. Herpes Zoste Drug Major Product Offerings
7.1.4 Astellas Pharma Inc. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.1.5 Astellas Pharma Inc. Key News
7.2 Beijing Minhai Biotechnology Co., Ltd
7.2.1 Beijing Minhai Biotechnology Co., Ltd Corporate Summary
7.2.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
7.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Major Product Offerings
7.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.2.5 Beijing Minhai Biotechnology Co., Ltd Key News
7.3 ContraVir Pharmaceuticals, Inc.
7.3.1 ContraVir Pharmaceuticals, Inc. Corporate Summary
7.3.2 ContraVir Pharmaceuticals, Inc. Business Overview
7.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Major Product Offerings
7.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.3.5 ContraVir Pharmaceuticals, Inc. Key News
7.4 Epiphany Biosciences, Inc.
7.4.1 Epiphany Biosciences, Inc. Corporate Summary
7.4.2 Epiphany Biosciences, Inc. Business Overview
7.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Major Product Offerings
7.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.4.5 Epiphany Biosciences, Inc. Key News
7.5 Foamix Pharmaceuticals Ltd.
7.5.1 Foamix Pharmaceuticals Ltd. Corporate Summary
7.5.2 Foamix Pharmaceuticals Ltd. Business Overview
7.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Major Product Offerings
7.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.5.5 Foamix Pharmaceuticals Ltd. Key News
7.6 GeneOne Life Science, Inc.
7.6.1 GeneOne Life Science, Inc. Corporate Summary
7.6.2 GeneOne Life Science, Inc. Business Overview
7.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Major Product Offerings
7.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.6.5 GeneOne Life Science, Inc. Key News
7.7 GlaxoSmithKline Plc
7.7.1 GlaxoSmithKline Plc Corporate Summary
7.7.2 GlaxoSmithKline Plc Business Overview
7.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Major Product Offerings
7.4.4 GlaxoSmithKline Plc Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.7.5 GlaxoSmithKline Plc Key News
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Corporate Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Herpes Zoste Drug Major Product Offerings
7.8.4 Merck & Co., Inc. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.8.5 Merck & Co., Inc. Key News
7.9 NAL Pharmaceuticals Ltd.
7.9.1 NAL Pharmaceuticals Ltd. Corporate Summary
7.9.2 NAL Pharmaceuticals Ltd. Business Overview
7.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Major Product Offerings
7.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.9.5 NAL Pharmaceuticals Ltd. Key News
7.10 ReceptoPharm, Inc.
7.10.1 ReceptoPharm, Inc. Corporate Summary
7.10.2 ReceptoPharm, Inc. Business Overview
7.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Major Product Offerings
7.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.10.5 ReceptoPharm, Inc. Key News
7.11 TSRL, Inc.
7.11.1 TSRL, Inc. Corporate Summary
7.11.2 TSRL, Inc. Herpes Zoste Drug Business Overview
7.11.3 TSRL, Inc. Herpes Zoste Drug Major Product Offerings
7.11.4 TSRL, Inc. Herpes Zoste Drug Sales and Revenue in Global (2016-2021)
7.11.5 TSRL, Inc. Key News
8 Global Herpes Zoste Drug Production Capacity, Analysis
8.1 Global Herpes Zoste Drug Production Capacity, 2016-2027
8.2 Herpes Zoste Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Herpes Zoste Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Herpes Zoste Drug Supply Chain Analysis
10.1 Herpes Zoste Drug Industry Value Chain
10.2 Herpes Zoste Drug Upstream Market
10.3 Herpes Zoste Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Herpes Zoste Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Herpes Zoste Drug in Global Market
Table 2. Top Herpes Zoste Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Herpes Zoste Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Herpes Zoste Drug Revenue Share by Companies, 2016-2021
Table 5. Global Herpes Zoste Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Herpes Zoste Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Herpes Zoste Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Herpes Zoste Drug Product Type
Table 9. List of Global Tier 1 Herpes Zoste Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Herpes Zoste Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Astellas Pharma Inc.
Beijing Minhai Biotechnology Co., Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences, Inc.
Foamix Pharmaceuticals Ltd.
GeneOne Life Science, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL, Inc.